AstraZeneca Securities Delisted by NYSE
Ticker: AZN · Form: 25-NSE · Filed: 2026-04-08T14:20:43-04:00
Sentiment: neutral
Topics: delisting, exchange-filing, securities
TL;DR
NYSE is delisting AstraZeneca securities on 4/8/26. Check your holdings.
AI Summary
On April 8, 2026, the New York Stock Exchange (NYSE) filed a Form 25-NSE to report the delisting of securities for AstraZeneca PLC. This action is typically taken for securities that have matured, been redeemed, or retired.
Why It Matters
This filing indicates that certain AstraZeneca securities will no longer be listed or traded on the NYSE, potentially impacting investors holding those specific securities.
Risk Assessment
Risk Level: low — This is a standard administrative filing for securities that have reached the end of their lifecycle on the exchange, not indicative of company distress.
Key Players & Entities
- NEW YORK STOCK EXCHANGE LLC (company) — Filer
- ASTRAZENECA PLC (company) — Subject Company
- 2026-04-08 (date) — Filing and Effectiveness Date
FAQ
What is the purpose of a Form 25-NSE filing?
A Form 25-NSE is filed by a national security exchange to report the removal from listing and registration of matured, redeemed, or retired securities.
Who is filing this Form 25-NSE?
The New York Stock Exchange LLC (NYSE) is filing this Form 25-NSE.
Which company's securities are being delisted?
AstraZeneca PLC's securities are being delisted.
When is the effectiveness date for this delisting?
The effectiveness date for this delisting is April 8, 2026.
What is AstraZeneca PLC's SIC code?
AstraZeneca PLC's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0000876661-26-000343 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: SEC Accession No. 0000876661-26-000343 Filing Date 2026-04-08 Accepted 2026-04-08 14:20:43 Documents 2 Effectiveness Date 2026-04-08 Document Format Files Seq Description Document Type Size 1 primary_doc.html 25-NSE 1 primary_doc.xml 25-NSE 1080 2 ruleprovisionnotice.htm EX-99.25 754 Complete submission text file 0000876661-26-000343.txt 3810 Mailing Address 11 WALL STREET NEW YORK NY 10005 Business Address 11 WALL STREET NEW YORK NY 10005 212-656-2060 NEW YORK STOCK EXCHANGE LLC (Filed by) CIK : 0000876661 (see all company filings) EIN. : 000000000 | State of Incorp.: NY Type: 25-NSE Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA 011 44 20 7304 5000 ASTRAZENECA PLC (Subject) CIK : 0000901832 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231 Type: 25-NSE | Act: 34 | File No.: 001-11960 | Film No.: 26847566 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)